Literature DB >> 24174165

TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas.

Hideyuki Arita1, Yoshitaka Narita, Hirokazu Takami, Shintaro Fukushima, Yuko Matsushita, Akihiko Yoshida, Yasuji Miyakita, Makoto Ohno, Soichiro Shibui, Koichi Ichimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24174165     DOI： 10.1007/s00401-013-1203-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  35 in total

1.  Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.

Authors:  Victoria Zigmont; Amy Garrett; Jin Peng; Michal Seweryn; Grzegorz A Rempala; Randall Harris; Christopher Holloman; Thomas E Gundersen; Anders Ahlbom; Maria Feychting; Tom Borge Johannesen; Tom Kristian Grimsrud; Judith Schwartzbaum
Journal:  Nutr Cancer       Date:  2015-08-28       Impact factor: 2.900

2.  Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.

Authors:  Catherine Gozé; Marie Blonski; Guillaume Le Maistre; Luc Bauchet; Edouard Dezamis; Philippe Page; Pascale Varlet; Laurent Capelle; Bertrand Devaux; Luc Taillandier; Hugues Duffau; Johan Pallud
Journal:  Neuro Oncol       Date:  2014-05-20       Impact factor: 12.300

Review 3.  The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.

Authors:  Julieann Lee; David A Solomon; Tarik Tihan
Journal:  J Neurooncol       Date:  2017-01-07       Impact factor: 4.130

4.  Diagnostic implications of TERT promoter mutation status in diffuse gliomas in a routine clinical setting.

Authors:  Ekkehard Hewer; Nadine Prebil; Sabina Berezowska; Marielena Gutt-Will; Philippe Schucht; Matthias S Dettmer; Erik Vassella
Journal:  Virchows Arch       Date:  2017-08-19       Impact factor: 4.064

5.  Role of traditional CHO PET parameters in distinguishing IDH, TERT and MGMT alterations in primary diffuse gliomas.

Authors:  Yucheng Zhang; Delin Liu; Ziren Kong; Penghao Liu; Yixin Shi; Yaning Wang; Dachun Zhao; Xin Cheng; Yu Wang; Wenbin Ma
Journal:  Ann Nucl Med       Date:  2021-02-02       Impact factor: 2.668

6.  Promoting a new brain tumor mutation: TERT promoter mutations in CNS tumors.

Authors:  Zachary J Reitman; Christopher J Pirozzi; Hai Yan
Journal:  Acta Neuropathol       Date:  2013-12       Impact factor: 17.088

7.  hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.

Authors:  Gina Fürtjes; Michaela Köchling; Susanne Peetz-Dienhart; Andrea Wagner; Katharina Heß; Martin Hasselblatt; Volker Senner; Walter Stummer; Werner Paulus; Benjamin Brokinkel
Journal:  J Neurooncol       Date:  2016-07-27       Impact factor: 4.130

8.  TERT promoter mutations contribute to subset prognostication of lower-grade gliomas.

Authors:  Aden Ka-Yin Chan; Yu Yao; Zhenyu Zhang; Nellie Yuk-Fei Chung; Joseph Shu-Ming Liu; Kay Ka-Wai Li; Zhifeng Shi; Danny Tat-Ming Chan; Wai Sang Poon; Liangfu Zhou; Ho-Keung Ng
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

9.  TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours.

Authors:  Janet C Lindsey; Ed C Schwalbe; Sandeep Potluri; Simon Bailey; Daniel Williamson; Steven C Clifford
Journal:  Acta Neuropathol       Date:  2013-12-12       Impact factor: 17.088

10.  TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.

Authors:  Kenji Fujimoto; Hideyuki Arita; Kaishi Satomi; Kai Yamasaki; Yuko Matsushita; Taishi Nakamura; Yasuji Miyakita; Toru Umehara; Keiichi Kobayashi; Kaoru Tamura; Shota Tanaka; Fumi Higuchi; Yoshiko Okita; Yonehiro Kanemura; Junya Fukai; Daisuke Sakamoto; Takehiro Uda; Ryunosuke Machida; Aya Kuchiba; Taketoshi Maehara; Motoo Nagane; Ryo Nishikawa; Hiroyoshi Suzuki; Makoto Shibuya; Takashi Komori; Yoshitaka Narita; Koichi Ichimura
Journal:  Acta Neuropathol       Date:  2021-06-20       Impact factor: 17.088
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.